Category: Smith & Nephew
Smith & Nephew introduces its Polarstem cementless total hip replacement stem to the American market.
Smith & Nephew (FTSE:SN, NYSE:SNN) said it's launching its Polarstem cementless hip stem in the United States for total hip replacement procedures.
ArthroCare creates a $15 million fund to transition its employees through the pending $1.7 billion acquisition by Smith & Nephew.
Smiths Medical president Srini Seshadri steps down, making way for Zimmer executive Jeff McCaulley.
Smiths Medical president Srini Seshadri is expected to step down, and Zimmer (NYSE:ZMH) executive Jeff McCaulley will step into the top office.
There was no reason given for Seshadri's departure. He joined the company in 2006 and helped navigate some tough times when it was under-performing, Smiths said.
Texas medical device maker ArthroCare falls short of Wall Street's expectations for its 4th quarter, with a 1.9% bump in profits on a 4.9% increase in sales.
The U.S. Patent & Trademark Office nixes 2 patents at issue in Smith & Nephew's long-running infringement battle with Interlace Medical and subsequent acquirer Hologic.
Smith & Nephew posted strong growth in sales and profits for its 4th quarter of 2013, touting progress in international and emerging markets.
Smith & Nephew may face some M&A competition as a Wall Street surge following its $1.7 billion offer makes ArthroCare more attractive to other potential buyers.